Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AbbVie Inc. ABBV: A Top Socially Responsible Dividend Stock

January 31, 2025
AbbVie Inc. (NYSE:ABBV) has recently emerged as one of the top socially responsible dividend stocks in the market. With a dividend yield of 3.9%, it presents an attractive opportunity for investors looking to add sustainability to their portfolio.

AbbVie is committed to providing innovative healthcare solutions while also making a positive impact on society. The company's dedication to corporate social responsibility has been recognized by various organizations, earning it a spot on the list of top socially responsible companies.

With a strong financial performance and consistent dividend payouts, AbbVie offers stability and growth potential. It continues to invest in research and development, ensuring a robust pipeline of new drugs and therapies.

In a recent development, AbbVie's stock position has decreased, as reported by OLD National Bancorp IN. This could be a strategic move by the firm or an indication of market trends. However, it is essential to consult professionals from Stocks Prognosis for a more accurate analysis of the stock's movement.

As we approach 2025, AbbVie Inc. could be an excellent stock to consider for beginners. Its commitment to social responsibility, coupled with financial stability, makes it an attractive investment option. For a comprehensive forecast on the future movement of AbbVie's stock, it is recommended to seek advice from professionals at Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for ABBV

Related data

ABBVAugust 20, 2025ABBVIE INC. Hits Forecast Price Target with 10.4% Profit: A Success Story for QuantWave  ~1 min.

On June 13, 2025, QuantWave issued a long signal for ABBVIE INC. when the stock was trading at 189.44 $. Fast forward to August 20, 2025, and the forecasted price target of 209....


ABBVAugust 14, 2025ABBVIE INC. Hits Price Target Forecast with 11.3% Profit: QuantWave Analysis  ~1 min.

ABBVIE INC. has successfully reached the price target forecast set by QuantWave, resulting in an impressive 11.3% profit for investors....


ABBVMarch 22, 2025AbbVie ABBV Stock Moves -0.29: What You Should Know  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, has recently experienced a slight decrease in stock movement. As an investor, it is essential to keep track of such fluctuations....


ABBVMarch 20, 2025AbbVie Inc. ABBV is Experiencing Global Investor Interest: A Look into the Company's Success Story  ~2 min.

AbbVie Inc., a renowned pharmaceutical company, has been making waves in the global market, attracting significant attention from investors worldwide....


ABBVMarch 19, 2025AbbVie Inc. ABBV: A Higher-Yielding Healthcare Play That Continues to Shine  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, is steadily gaining the attention of investors. With its continuous success in the healthcare industry, AbbVie has become a top choice for hedge funds....


ABBVMarch 18, 2025The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell, and Hamilton Beach Brands  ~1 min.

According to a recent analysis by Zacks, AbbVie Inc. (ABBV) is considered one of the top healthcare stocks to invest in....


ABBVMarch 14, 2025AbbVie Inc. ABBV is Attracting Investor Attention: Here is What You Should Know  ~2 min.

AbbVie Inc. (ABBV) has been grabbing the attention of investors recently with its impressive performance in the healthcare sector....


ABBVMarch 10, 2025ABBVIE INC. Hits Price Target Forecast with 15.28% Profit – A Triumph for QuantWave's Analytics  ~1 min.

ABBVIE INC. achieved a significant milestone as it hit the price target forecast set by QuantWave, resulting in a profit of 15.28%....


ABBVMarch 10, 2025ABBVIE INC. Hits Price Target Forecast on QuantWave with 15.28% Profit Margin  ~1 min.

AbbVie Inc. (ABBV) has successfully reached the price target forecast on QuantWave, signaling a profitable long position for investors. The forecast, initiated on August 13, 2024, at a price of $184....


ABBVFebruary 28, 2025QuantWave Forecast Success: ABBVIE INC. Hits Price Target with 13.87% Profit  ~2 min.

On July 30, 2024, QuantWave issued a long signal for ABBVIE INC. stock when it was priced at 180.33 $....


ABBVNovember 10, 2024Klingman Associates LLC Increases Position in AbbVie Inc. ABBV  ~1 min.

Klingman Associates LLC, a notable investment firm, recently increased its position in AbbVie Inc. (NYSE:ABBV)....


ABBVDecember 21, 2024AbbVie ABBV Stock Shows Resilience Amid Market Turmoil  ~1 min.

AbbVie Inc. (NYSE:ABBV) has managed to buck the trend and maintain its stock position amidst a turbulent market....


ABBVNovember 7, 2024TipRanks.com Is AbbVie NYSE:ABBV Stock a Buy After Its Dividend Hike  ~1 min.

AbbVie Inc. (ABBV) recently announced a significant increase in its dividend payout, making its stock an attractive investment. According to TipRanks....


ABBVOctober 28, 2024AbbVie Inc. Attracts Investor Attention with 73% Institutional Ownership  ~1 min.

AbbVie Inc. (NYSE:ABBV), a leading pharmaceutical company, has caught the attention of investors due to its high institutional ownership....


ABBVOctober 31, 2024AbbVie Reports Third-Quarter 2024 Financial Results  ~1 min.

AbbVie Inc. (NYSE:ABBV) announced its financial results for the third quarter of 2024, showcasing impressive growth and exceeding market expectations....